医脉通根据首次公开发售前购股权计划而发行合共93万股

Core Viewpoint - The company, 医脉通 (02192), announced the issuance of a total of 930,000 ordinary shares on January 5, 2026, as part of its pre-IPO share option plan adopted on March 29, 2021 [1] Group 1 - The company will issue 700,000 ordinary shares to two directors exercising their share options [1] - An additional 230,000 ordinary shares will be issued to one employee exercising their share options [1]